Diabetes Mellitus/ Prediabetes abstracts

Select a category and search by Poster #, Author, or Title. Please Note: You may only search for an Abstract within it's assigned category.

POSTER # PRIMARY AUTHOR TITLE
200 Orighomisan Agboghoroma THE RELATIONSHIP BETWEEN ALBUMIN EXCRETION RATE AND ESTIMATED GLOMERULAR FILTRATION RATE IN NIGERIAN PATIENTS WITH TYPE 2 DIABETES MELLITUS
201 Orighomisan Agboghoroma HEALTH RELATED QUALITY OF LIFE OF ADULTS WITH DIABETES MELLITUS IN JOS
202 Patricia Mejia Osuna INDEPENDENT AND ADDITIVE PROGNOSTIC VALUE OF PRETRANSPLANT DIABETES MELLITUS FOR EARLY CARDIOVASCULAR COMPLICATIONS AFTER ORTHOTROPIC LIVER TRANSPLANTATION
203 Foiqa Chaudhry DIABETIC KETOACIDOSIS FOLLOWING SGLT2 INHIBITOR THERAPY IN DM2
204 Derek O'Keeffe THE MANAGEMENT OF DIABETES MELLITUS IN NEW IRELAND PAPUA NEW GUINEA
205 Rekha Kambhampati ORAL HYPOGLYCEMICS: ARE THEY ENOUGH?
206 Maja Udovcic GUIDELINES TO IMPROVE PERIOPERATIVE MANAGEMENT OF DIABETES MELLITUS: ASSESSMENT OF THE IMPACT OF CHANGE ACROSS TIME
207 Narjust Duma THE IMPACT OF DIABETES MELLITUS AND FASTING GLUCOSE LEVELS ON CLINICAL OUTCOMES IN COLORECTAL CANCER.
208 Simran Brar DELAYED-ONSET INSULIN ALLERGY IN A PATIENT WITH DIABETES MELLITUS TYPE II
211 Folake Akanbi NECK CIRCUMFERENCE AS AN INDICATOR OF METABOLIC SYNDROME
212 Tanya Blaty EFFECT OF OUTPATIENT DIABETES EDUCATION ON CLINICAL OUTCOMES
213 Esti Charlap A CASE OF MULTIPLE PRESENTATIONS OF METFORMIN-INDUCED LACTIC ACIDOSIS OCCURING IN A SINGLE PATIENT
214 Chibuike Chukwunyere GESTATIONAL DIABETES IN A TERTIARY HEALTHCARE CENTRE IN ABEOKUTA: A FIVE YEAR RETROSPECTIVE REVIEW
215 Adenike Enikuomehin TREATMENT GOALS ATTAINMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AT THE OBAFEMI AWOLOWO UNIVERSITY TEACHING HOSPITAL, ILE-IFE SOUTH WEST NIGERIA
216 Anette Garces-Dominguez KNOWLEDGE ABOUT INPATIENT DIABETES MANAGEMENT: IMPACT OF AN EDUCATIONAL INTERVENTION IN NURSES AT THE UNIVERSITY HOSPITAL OF PUERTO RICO
217 Akolade Idowu COMBINED PREDICTABILITY OF PHYSICAL ACTIVITY AND BODYWEIGHT ON HEALTH-RELATED QUALITY OF LIFE AMONG NIGERIAN TYPE 2 DIABETES MELLITUS
218 Mose July IS IT GOUT, CELLULITIS OR CHARCOT NEUROPATHIC OSTEOARTHROPATHY?
219 Narayan KC PERITONSILLAR ABSCESS LEADING TO HYPEROSMOLAR HYPERGLYCEMIC STATE IN NON-DIABETIC PATIENT
220 Bayan Mesmar SIMULATION USING STANDARDIZED PATIENTS FOR FOOT EXAMINATION IN DIABETES
221 Natalie Mora EMPHYSEMATOUS PYELONEPHRITIS IN A PATIENT WITH TYPE 2 DIABETES
222 Fakhraddeen Muhammad DYSGLYCAEMIA AMONG HIV PATIENTS ON HIGHLY ACTIVE ANTIRETROVIRAL THERAPY IN KANO, NORTH WESTERN NIGERIA
223 Timothy Petersen DIABETES MEDICATIONS IN PATIENTS WITH LEFT VENTRICULAR ASSIST DEVICES: SAFETY AND EFFICACY
224 Muhammad Shahid A RANDOMIZED CONTROLLED TRIAL OF MOBILE PHONE INTERVENTION TO IMPROVE DIABETES CARE IN RURAL AREAS
225 Monica Vega THE EFFECTIVENESS OF AN INPATIENT HYPERGLYCEMIA MANAGEMENT EDUCATIONAL PROGRAM AMONG INTERNAL MEDICINE RESIDENTS
226 Aaron Vinik BARIATRIC SURGERY RESTORES SOMATIC AND AUTONOMIC NERVE FUNCTION TOWARDS NORMAL IN OBESE PATIENTS WITH AND WITHOUT DIABETES
227 Parmis Motavalli THE EFFECT OF INNER SEED PADDLE OF WALNUT ON BLOOD GLUCOSE
228 Nazmul Kabir Qureshi FOOT CARE IN DIABETES: KNOWLEDGE & PRACTICE PATTERN AMONG URBAN & SUBURBAN BANGLADESHI TYPE 2 DIABETIC SUBJECTS.
229 Luisa Leal AN INTEGRATIVE REVIEW OF LITERATURE OF REGULAR R U-500 INSULIN IN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION
230 Issac Sachmechi BULLOUS PEMPHIGOID-ADVERSE REACTION TO LINAGLIPTIN (TRADJENTA): A CASE REPORT
231 Scott Lee PUMP THERAPY SUPERIOR TO FURTHER INTENSIFICATION OF MULTIPLE DAILY INJECTION THERAPY IN TYPE 2 DIABETES
232 Paresh Dandona EFFECT OF LIRAGLUTIDE ON POST PRANDIAL GLUCAGON, CARBOHYDRATE INTAKE AND ON INFLAMMATION IN PATIENTS WITH TYPE 1 DIABETES
233 Brijendra Srivastava PRE-IMPAIRED GLUCOSE TOLERANCE, A RISK FACTOR FOR DIABETES PROGRESSION IN ASIAN INDIANS
234 Lawrence Leiter SIMULTANEOUS REDUCTION IN BOTH A1C AND BODY WEIGHT WITH CANAGLIFLOZIN VERSUS GLIMEPIRIDE IN METFORMIN-TREATED PATIENTS WITH TYPE 2 DIABETES OVER 104 WEEKS
235 Aaron Vinik LONG-TERM SAFETY AND EFFICACY OF REPEATED APPLICATIONS OF CAPSAICIN 8% PATCH (QUTENZATM) IN PAINFUL DIABETIC PERIPHERAL NEUROPATHY: PACE STUDY
236 Subodh Banzal COMPARISON OF INSULIN GLARGINE WITH HUMAN PREMIX INSULIN IN PATIENTS WITH TYPE 2 DIABETES INADEQUATELY CONTROLLED ON ORAL HYPOGLYCEMIC DRUGS IN A 24 WEEK RANDOMIZED STUDY
237 Nayananjani Karunasena TYPE 2 DIABETES AND CARDIOVASCULAR DISEASE RISK: AN AGE CUTOFF TO INITIATE STATINS WITHOUT A BASELINE LIPID PROFILE
239 Amy Larkin EFFECTIVENESS OF ONLINE MEDICAL EDUCATION AT IMPROVING TYPE 2 DIABETES MANAGEMENT
240 Alan  Boonin IMPROVED GLYCEMIC CONTROL UTILIZING BASAL BOLUS INSULIN DELIVERY WITH THE V-GO® DISPOSABLE INSULIN DELIVERY DEVICE IN THE LONG-TERM CARE SETTING
241 Saleh Aldasouqi TECHNICAL PITFALLS OF INSULIN PUMPS INTERNAL CLOCKS: AN EXAMPLE OF AN AM-PM GLITCH
242 Christopher  Russo THE PREVALENCE OF DIABETIC RETINOPATHY IN PREGNANT HISPANIC WOMEN WITH PRE-EXISTING DIABETES MELLITUS OR GESTATIONAL DIABETES MELLITUS
243 Fazlarabbi Khan REGIMEN ADHERENCE, GLYCEMIC CONTROL AND PARENTING KNOWLEDGE IN PATIENT WITH TYPE 1 DIABETES IN BANGLADESH
244 Banshi Saboo PREVALENCE OF GROWTH HORMONE DEFICIENCY IN TYPE1 DM PATIENTS AT A TERTIARY CARE CENTRE IN INDIA
245 Mohsen Eledrisi TWICE-DAILY INSULIN GLARGINE FOR GLUCOSE CONTROL IN ENTERAL NUTRTION THERAPY
246 Ofem Enang INTERMEDIATE METABOLIC STATES AND DIABETES MELLITUS IN AN URBAN NIGERIAN POPULATION
247 Brij Makkar VITAMIN D DEFICIENCY IN PATIENTS WITH TYPE 2 DIABETES IN NORTH INDIAN POPULATION
248 Rosemarie Lajara UTILIZATION OF REGULAR INSULIN IN V-GO® FOR PATIENTS UNCONTROLLED WITH TYPE 2 DIABETES MELLITUS (T2DM): A CASE SERIES
249 Rashi Agarwal EFFECTIVENESS OF A MULTIDISCIPLINARY TEAM FOR DIABETES MANAGEMENT IN A RURAL PRIMARY CARE OFFICE
250 Amal Madanat DIABETIC PERIPHERAL NEUROPATHY AMONG SAUDI PATIENTS WITH NEWLY DIAGNOSED TYPE 2 DIABETES MELLITUS.
251 Manish Gutch CORRELATION OF LEFT VENTRICULAR HYPERTROPHY & LEFT VENTRICULAR DIASTOLIC DYSFUNCTION WITH HBA1C IN NEWLY DIAGNOSED TYPE 2 DIABETICS
252 Amparo de la Pena ONCE WEEKLY DULAGLUTIDE MAY BE COADMINISTERED WITH WARFARIN WITHOUT DOSE ADJUSTMENT
253 Ignatius Ezeani INSULIN USE AMONG PATIENTS WITH DIABETES MELLITUS, CHALLENGES WITH ADMINISTRATION AND STORAGE: A NARRATIVE FROM UMUAHIA
254 Sudhir Bhandari INDEPENDENT PREDICTORS OF ERECTILE DYSFUNCTION (ED) IN TYPE - 2 DIABETES MELLITUS
255 Najim Abdulwahid COMPARATIVE STUDY BETWEEN THE EFFECTS OF SITAGLIPTIN AND VILDAGLIPTIN AS ORAL HYPOGLYCEMIC DRUGS IN UNCONTROLLED TYPE II DIABETES MELLITUS
256 Rochsis Mandoko COMPARISON OF ACID FAST BACILLI SMEAR MICROSCOPY EXAMINATION AND X-PERT MTB/RIF IN DIAGNOSIS PULMONARY TUBERCULOSIS IN TYPE 2 DIABETES
257 Nour Batarseh CELIAC CRISIS : A RARE COMPLICATION IN AN ADULT PATIENT WITH TYPE Ι DIABETES
258 Saleh Aldasouqi TECHNICAL PITFALLS OF INSULIN PUMPS INTERNAL CLOCKS: AN EXAMPLE OF A DAYLIGHT SAVING TIME GLITCH
259 Olufunmilayo Adeleye SELF GLUCOSE MONITORING PRACTICES, ITS IMPACT ON GLYCEMIC CONTROL AND PRESENCE OF CHRONIC COMPLICATIONS IN TYPE 2 DIABETIC PATIENTS.
260 Amy Larkin TARGETING SGLT2 INHIBITION IN T2D MANAGEMENT: EFFECT OF ONLINE CME AND CONTINUED EDUCATIONAL GAPS
262 Riyad Sulimani CLINICAL PROFILE AND OUTCOME OF DIABETIC KETOACIDOSIS AMONG SAUDI ADOLESCENT DIABETIC PATIENTS IN A SAUDI TERTIARY CENTER
263 Zdravko Kamenov IRISIN IN THE GLUCOSE CONTINUUM – FROM NORMAL GLUCOSE TOLERANCE THROUGH PREDIABETES TO TYPE 2 DIABETES MELLITUS
264 David Oyer IMPACT OF CANAGLIFLOZIN IN TYPE 2 DIABETIC PATIENTS IN A REAL WORLD SETTING
265 Mayme Wong TRENDS OF INCIDENT AND PREVALENT USE OF HUMAN REGULAR U-500 INSULIN OVER A 9-YEAR PERIOD IN THE UNITED STATES
266 Shahjada Selim PREVALENCE AND PATTERN OF CHRONIC COMPLICATIONS OF TYPE 2 DIABETES AMONG BANGLADESHI POPULATION
267 Michael Davies INCIDENCE OF GENITAL MYCOTIC INFECTIONS DECLINES OVER TIME IN PATIENTS WITH TYPE 2 DIABETES MELLITUS TREATED WITH CANAGLIFLOZIN OVER 2 YEARS
268 Deep Dutta INCREASED SERUM FETUIN-A IS AN IMPORTANT ADVERSE PREDICTOR OF GLYCEMIC OUTCOMES IN PREDIABETES: A 4 YEAR PROSPECTIVE STUDY FROM INDIA
269 Sheila Corrigan PHARMACOKINETIC BIOEQUIVALENT AND NON-BIOEQUIVALENT CONCENTRATED INSULIN FORMULATIONS: IMPLICATIONS FOR CLINICAL USE AND DOSING
270 Sheela Metgud OUTCOMES OF A STANDARDIZED PROTOCOL FOR DIABETES MANAGEMENT IN SURGICAL INPATIENTS
271 Luigi Meneghini IMPACT OF PREGABALIN ON SIGNS AND SYMPTOMS OF GASTROPARESIS
272 Rosemarie Lajara EXPERIENCE USING V-GO® IN PATIENTS WITH LATENT AUTOIMMUNE DIABETES OF THE ADULT (LADA) AND TYPE 1 DIABETES
273 Rosemarie Lajara EVALUATING THE EFFECT OF V-GO® THERAPY IN SUB-OPTIMALLY CONTROLLED PATIENTS WITH DIABETES – A RETROSPECTIVE COHORT ANALYSIS IN A LARGE SPECIALIZED DIABETES SYSTEM
274 Carol Smyth ELEVATED AST AND ALT RESULTS AND AN AST/ALT RATIO BETWEEN 0.7 AND 1.0 LINKED TO AN INCREASED RISK OF NASH IN PATIENTS WITH DIABETES
275 Fida Al-Atrash THE CDE-AMBASSADOR: A NOVEL APPROACH TO CONTROL DIABETES AT THE PRIMARY CARE LEVEL LEADS TO SIGNIFICANT IMPROVEMENT IN GLYCEMIC CONTROL AND CARDIOVASCULAR RISK FACTORS
276 Bithika Thompson INSULIN PUMP THERAPY USE DURING SURGERY: AN UPDATE ON A QUALITY INITIATIVE
277 Jeffery Cobb SELECTIVE BIOMARKERS OF ISOLATED IFG (IIFG) AND ISOLATED IGT (IIGT)
278 Jothydev Kesavadev INSULIN PUMPS FOR "LIFE" VS INSULIN PUMPS FOR "LUXURY"-THE INDIAN EXPERIENCE IN TYPE 2 DIABETES
279 Harold Pretorius LIVER DISEASE CONTRIBUTES TO COGNITIVE IMPAIRMENT ASSOCIATED WITH INADEQUATE GLYCEMIC CONTROL IN PATIENTS WITH MULTIPLE ENDOCRINE AND METABOLIC ABNORMALITIES
280 Evangeline Costelo A PREVALENCE SURVEY OF PEDIATRIC TYPE 2 DIABETES MELLITUS AMONG PATIENTS OF FILIPINO PHYSICIANS
282 Ildiko Lingvay EFFICACY AND SAFETY OF NEW INSULIN GLARGINE 300 U/ML IN BASAL INSULIN-TREATED PATIENTS WITH TYPE 2 DIABETES MELLITUS USING SELECTED COMPREHENSIVE DIABETES CARE HEDIS MEASURES
283 Yin Kon EFFECT OF TEAM-BASED CLINICAL INTERVENTION ON GLYCAEMIC CONTROL AND VARIABILITY IN TYPE 2 DIABETIC CHRONIC HAEMODIALYSIS PATIENTS: REPORT OF 2 CASES
284 Sailesh Lodha WOLFRAM SYNDROME : CLINICAL AND GENETIC DATA OF SIX PATIENTS FROM NON CONSANGUINEOUS FAMILIES
285 Surya Singh LINAGLIPTIN: A POTENT ANTI-INFLAMMATORY AGENT
286 Richard Pinsker VANISHING HEMICHOREA-HEMIBALLISMUS DUE TO NONKETOTIC HYPERGLYCEMIA: AN UNUSUAL PRESENTATION
287 Salisu Muazu CORRELATES OF SECONDARY FAILURE TO ORAL HYPOGLYCAEMIC AGENTS AMONG TYPE TWO DIABETES PATIENTS IN ZARIA, NORTHERN NIGERIA.
288 Manash Baruah ALTERNATE DAY DOSING OF LINAGLIPTIN 5MG IN PATIENTS CONTROLLED ON ONCE DAILY DOSE: A CASE SERIES
289 Rochsis Mandoko ANALYSIS OF FACTORS ASSOCIATED WITH THE OCCURENCE OF PULMONARY TUBERCULOSIS IN PATIENTS WITH TYPE 2 DIABETES
290 Tarik Elhadd THE CHALLENGES OF RAMADAN & DIABETES IN THE WESTERN HEMISPHERES: THE ROLE OF PRE-RAMADAN DIABETES CLINICS IN PATIENTS’ CARE & SAFETY
291 Najim Abdulwahid REGISTRY STUDY FOR TYPE II DIABETES MELLITUS PATIENTS IN DIABETIC CENTER WITH COMPARATIVE ANALYSIS FOR CONTROLLED VERSUS UNCONTROLLED CASES